165 related articles for article (PubMed ID: 8399782)
21. CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
Pohl C; Renner C; Schwonzen M; Schobert I; Liebenberg V; Jung W; Wolf J; Pfreundschuh M; Diehl V
Int J Cancer; 1993 May; 54(3):418-25. PubMed ID: 8389737
[TBL] [Abstract][Full Text] [Related]
22. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
[TBL] [Abstract][Full Text] [Related]
23. Influence of syngeneic monoclonal anti-idiotypic antibodies to murine monoclonal antibodies against tumour-associated antigens on the biodistribution of their target antibodies and their fragments.
Pimm MV; Demignot S; Gribben SJ
J Cancer Res Clin Oncol; 1993; 119(7):408-14. PubMed ID: 8491761
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal anti-idiotypic and anti-anti-idiotypic antibodies from mice immunized with a protective monoclonal antibody against Schistosoma mansoni.
Percy AJ; Harn DA
J Immunol; 1988 Apr; 140(8):2760-2. PubMed ID: 3128609
[TBL] [Abstract][Full Text] [Related]
25. Induction of immunity to a human osteosarcoma-associated antigen in mice using anti-idiotypic antibodies.
Warren RQ; Tsang KY
Clin Immunol Immunopathol; 1990 Sep; 56(3):334-43. PubMed ID: 2390811
[TBL] [Abstract][Full Text] [Related]
26. [Generation of genetic engineering anti-idiotypic antibody against OC125 monoclonal antibody of ovarian carcinoma].
Zhang X; Cui H; Qian H
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):646-8. PubMed ID: 9387521
[TBL] [Abstract][Full Text] [Related]
27. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
Irvine K; Schlom J
Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies and idiotypic network activation for ovarian carcinoma.
Wagner U; Reinsberg J; Schmidt S; Mallmann P; Schmolling J; Schultes B; Richter H; Biersack HJ; Krebs D
Cell Biophys; 1994; 24-25():237-42. PubMed ID: 7736528
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients.
Herlyn D; Harris D; Zaloudik J; Sperlagh M; Maruyama H; Jacob L; Kieny MP; Scheck S; Somasundaram R; Hart E
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):303-11. PubMed ID: 8061902
[TBL] [Abstract][Full Text] [Related]
30. Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.
Schobert I; Renner C; Pfreundschuh M; Diehl V; Pohl C
Leuk Lymphoma; 1994 May; 13(5-6):429-40. PubMed ID: 8069188
[TBL] [Abstract][Full Text] [Related]
31. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
[TBL] [Abstract][Full Text] [Related]
32. Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres.
Ma J; Samuel J; Kwon GS; Noujaim AA; Madiyalakan R
Cancer Immunol Immunother; 1998 Sep; 47(1):13-20. PubMed ID: 9755874
[TBL] [Abstract][Full Text] [Related]
33. Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response.
Ma J; Zhou L; Wang D
Jpn J Cancer Res; 2002 Jan; 93(1):78-84. PubMed ID: 11802811
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of anti-idiotypic antibodies and of their F(ab')2 fragments.
Tassi V; Ruggiero G; Rosaia L; Lorenzoni P; Ceccarini C; Tecce MF
Immunol Lett; 1991 Jan; 27(1):39-43. PubMed ID: 1708352
[TBL] [Abstract][Full Text] [Related]
35. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
Cornelissen JJ; Maassen K; van Emst L; Weers PM; Harmsen M; Benaissa-Trouw BJ; Oosterlaken TA; Kraaijeveld CA; Verhoef J
Immunology; 1993 Aug; 79(4):673-80. PubMed ID: 8406595
[TBL] [Abstract][Full Text] [Related]
36. Idiotypic restriction of murine monoclonal antibodies to a defined antigenic region of human thyroglobulin.
Del Rio M; Pau B; Bastide M; Bouanani M
Immunol Invest; 1995 Aug; 24(5):655-67. PubMed ID: 8543331
[TBL] [Abstract][Full Text] [Related]
37. Influence of a syngeneic anti-idiotypic antibody response to a mouse anti-tumour monoclonal antibody on biodistribution of its radiolabelled Fc-intact monovalent Fab/c fragment.
Pimm MV; Gribben SJ
Nucl Med Biol; 1994 Jan; 21(1):125-7. PubMed ID: 9234274
[TBL] [Abstract][Full Text] [Related]
38. Mouse monoclonal anti-idiotypic antibodies to HIV p24: immunochemical properties and internal imagery.
Hohmann A; Peters V; Comacchio R; Bradley J
Mol Immunol; 1993 Apr; 30(6):521-7. PubMed ID: 8487775
[TBL] [Abstract][Full Text] [Related]
39. Characterization of primate antibody responses to administered murine monoclonal immunoglobulin.
Milenic DE; Detrick B; Reynolds JC; Colcher D
Int J Biol Markers; 1990; 5(4):177-87. PubMed ID: 2093733
[TBL] [Abstract][Full Text] [Related]
40. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
Herlyn D; Ross AH; Iliopoulos D; Koprowski H
Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
